Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
This intro covers scenarios where a price-weighted index may be appropriate and how it contrasts with alternative indexing methods.
22,669 articlesA cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Drones and government funding chatter are reshaping investor sentiment. Ondas is at the center of the action, with ot...
U.S. investors will soon access perpetual futures, a cornerstone of the hottest crypto products world, under a new re...
Bitcoin wobbled amid renewed volatility as traders weigh key support levels and the risk of capitulation, with analys...
Investors are weighing Credo Technology Group after its latest earnings report. This article breaks down what the res...
Usio's Q4 2025 earnings reveal a business building momentum in payments services. This analysis breaks down the numbe...
Retailers are deploying in-store and online tactics that leverage human psychology to boost spending. Investors are e...
As 2026 approaches, two semiconductor giants chart divergent paths: TSMC powers AI chips through its foundry leadersh...
ASML’s stock rally has outpaced the broader market as AI-driven capex and a tightly controlled EUV backbone push back...
Despite a historic collapse, a stubborn community remains around Terra Luna Classic. This article explores who these ...
American Airlines is pausing six domestic routes this summer amid spike in jet fuel costs tied to Middle East tension...
Circle debuted CirBTC on Ethereum, a 1:1 BTC-backed ERC-20 token with real-time reserve proof, targeting institutiona...